Psoriasis Awareness Month

United States, Canada, United Kingdom, Australia

About

Psoriasis Awareness Month is observed throughout August to raise understanding of psoriasis, a chronic condition that can cause visible patches, itching, discomfort, and other symptoms. The observance helps replace misconceptions with accurate information and reminds people that psoriasis is not contagious. It also highlights the many ways the condition can affect daily life, confidence, and emotional well-being.

Throughout the month, individuals, healthcare professionals, and advocacy organizations are encouraged to share experiences, promote compassionate support, and learn more about available treatments and care. Psoriasis Awareness Month is an opportunity to stand with people living with psoriasis, encourage meaningful conversations, and foster a more informed and accepting community.

History

Psoriasis Awareness Month is observed throughout August to increase public understanding of psoriasis, a chronic inflammatory disease that causes raised, scaly patches on the skin. The observance developed from efforts by patients, dermatology professionals, and advocacy organizations to correct misconceptions about the condition. For much of history, visible skin diseases were poorly understood and sometimes confused with contagious infections. Psoriasis is not contagious, but the mistaken belief that it can spread through contact has contributed to stigma and social isolation.

The history of psoriasis itself extends back to the ancient world, although early physicians did not always distinguish it clearly from other skin disorders. In the nineteenth century, medical researchers began separating psoriasis from related conditions and describing its characteristic patterns more systematically. Later medical research identified psoriasis as an immune-mediated disease involving inflammation and an accelerated growth cycle in skin cells. These developments helped move public discussion away from ideas that psoriasis resulted from poor hygiene or personal failure.

Over time, Psoriasis Awareness Month has evolved beyond explaining the appearance of the disease. Awareness campaigns now emphasize that psoriasis can affect people of all ages and may be associated with other health concerns, including psoriatic arthritis and cardiovascular or metabolic conditions. They also highlight the importance of diagnosis, ongoing medical care, and treatment options ranging from topical medicines and phototherapy to oral and biologic therapies. Patient organizations use the month to share educational resources, encourage conversations with health professionals, and draw attention to the emotional effects of living with a visible chronic illness.

Culturally, the observance gives people with psoriasis a stronger public voice and challenges appearance-based prejudice. Throughout August, campaigns commonly encourage empathy, accurate language, and recognition that the condition affects more than the skin. By combining medical education with patient advocacy, Psoriasis Awareness Month has helped broaden the understanding of psoriasis from a cosmetic concern to a complex, lifelong health condition deserving of informed care and social support.

Timeline

1967
The National Psoriasis Foundation was founded in the United States to support people with psoriasis and advance education, advocacy, and research.
2003
The U.S. Food and Drug Administration approved alefacept (Amevive) for adults with moderate-to-severe chronic plaque psoriasis. It was the first biologic therapy approved for psoriasis.
2004
The U.S. Food and Drug Administration approved etanercept (Enbrel) for adults with chronic moderate-to-severe plaque psoriasis.
2009
The U.S. Food and Drug Administration approved ustekinumab (Stelara) for adults with moderate-to-severe plaque psoriasis.
2015
The U.S. Food and Drug Administration approved secukinumab (Cosentyx) for adults with moderate-to-severe plaque psoriasis.

Upcoming dates

Sources

Same day

Related